Clinical Trial Update: Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium [NA]

View source ↗

Summary

A randomized controlled trial evaluating subconjunctival bevacizumab injections to prevent recurrence in impending recurrent pterygium has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium of the Conjunctiva and Cornea

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Pterygium of the Conjunctiva and Cornea | NA | Status: COMPLETED